Lv6
1980 积分 2024-03-05 加入
HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody–Drug Conjugate Drug Development in Solid Tumors
19小时前
已完结
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
28天前
已完结
WEE-family kinases in cancer: synthetic lethal interactions and drug discovery
1个月前
已完结
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
1个月前
已完结
New payloads drive next-gen antibody–drug conjugates
2个月前
已完结
Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications
2个月前
已完结
A Review of Recent Alpha and Beta Emitters in Translational Nuclear Medicine
2个月前
已关闭
Recent advances in coordination chemistry on the application and development of radiopharmaceuticals and boron neutron capture therapy
2个月前
已完结
The landscape for radioligand therapies in oncology
3个月前
已完结
From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation
4个月前
已关闭
皖公网安备34019202002308
